Soothe Lubricant Eye

Phase 2Small molecule

Soothe Lubricant Eye is one of 10 small molecule programs targeting Keratoconjunctivitis sicca. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Keratoconjunctivitis SiccaActive, not recruiting

Keratoconjunctivitis SiccaPhase 2

Active, not recruiting

Competition

Competitive Landscape

18 competitors in Keratoconjunctivitis Sicca

#DrugCompanyPhaseTrials

Lotemax

BBausch & Lomb Incorporated

Neoral

1 3

Alphagan

AbbVie

Phase 3

—4

Elidel

BBausch Health Americas, Inc.

Phase 2

1 5

CF101

CCan-Fite BioPharma

Phase 2

1 6

Lupkynis

Aurinia Pharmaceuticals

Phase 1

1 7

Restasis

Aurinia Pharmaceuticals

Phase 2

1 8

Lotemax

MMedical University of South Carolina

Phase 2

1 9

Mucosta

Otsuka

Preclinical

1 10

Soothe Lubricant Eye

BBausch & Lomb Incorporated

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Keratoconjunctivitis sicca1 trial

Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)

Completed·BBausch & Lomb Incorporated·Phase 2·NCT01817582·102 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Soothe Lubricant Eye. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Soothe Lubricant Eye compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Soothe Lubricant Eye. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Bausch & Lomb Incorporated company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: BBausch & Lomb Incorporated

Soothe Lubricant Eye

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Keratoconjunctivitis sicca1 trial

References

Drug Info

Quick Facts

Related News